Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients: A Prospective Randomized Trial of Two Approaches to Wound Drainage

NCT04680182 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04680182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04680182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients: A Prospective Randomized Trial of Two Approaches to Wound Drainage
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 11, 2018
Completion date
September 1, 2022
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication, melanoma